BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 20704077)

  • 21. Reactive perforating leprosy, erythema multiforme-like reactions, sweet's syndrome-like reactions as atypical clinical manifestations of Type 2 leprosy reaction.
    Gunawan H; Yogya Y; Hafinah R; Marsella R; Ermawaty D; Suwarsa O
    Int J Mycobacteriol; 2018; 7(1):97-100. PubMed ID: 29516895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Severe form of type 2 reaction in patients of Hansen's disease after withdrawal of thalidomide: case reports.
    Rattan R; Shanker V; Tegta GR; Verma GK
    Indian J Lepr; 2009; 81(4):199-203. PubMed ID: 20704076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cutaneous ulceration as a presenting feature of type 1 lepra reaction: A case report.
    Hegde P; Jaiswal D; Shetty VM; Pai K; Rao R
    Trop Doct; 2022 Apr; 52(2):354-356. PubMed ID: 35006027
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Azathioprine in controlling type 2 reactions in leprosy: a case report.
    Athreya SP
    Lepr Rev; 2007 Sep; 78(3):290-2. PubMed ID: 18035780
    [No Abstract]   [Full Text] [Related]  

  • 25. Subcorneal pustular dermatosis in type 2 lepra reaction.
    Pavithran K
    Int J Lepr Other Mycobact Dis; 1992 Mar; 60(1):89-91. PubMed ID: 1602201
    [No Abstract]   [Full Text] [Related]  

  • 26. Histopathological lesions of apparently normal skin in leprosy patients.
    Rashed HA; Mearag I; Saleh NM; Saied A
    J Egypt Soc Parasitol; 2009 Dec; 39(3):933-42. PubMed ID: 20120756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Guillain-Barré syndrome-like presentation in borderline leprosy with type-2 reaction.
    Rai VM; Shenoi S; Rao SN
    Dermatol Online J; 2006 Feb; 12(2):21. PubMed ID: 16638414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histopathology of the lepromatous skin biopsy.
    Massone C; Belachew WA; Schettini A
    Clin Dermatol; 2015; 33(1):38-45. PubMed ID: 25432809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lepromatous leprosy presenting with type II reaction before and type I reaction after treatment.
    Robati RM; Mozafari N; Bidari-Zerehpoosh F; Niknejad N; Bizaval Z
    Dermatol Online J; 2020 Sep; 26(9):. PubMed ID: 33054941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lepromatous leprosy in Saudi female from central region.
    al-Majed S
    J Hyg Epidemiol Microbiol Immunol; 1991; 35(2):163-6. PubMed ID: 1940331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Two microbiological relapses in a patient with lepromatous leprosy.
    Chakma JK; Girdhar A; Natrajan M; Kumar A; Girdhar BK
    Lepr Rev; 2008 Sep; 79(3):331-4. PubMed ID: 19009984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Erythema nodosum leprosum: reactional leprosy.
    Cuevas J; Rodríguez-Peralto JL; Carrillo R; Contreras F
    Semin Cutan Med Surg; 2007 Jun; 26(2):126-30. PubMed ID: 17544965
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Necrotic erythema nodosum leprosum with oral mucosal involvement.
    Swain JP; Soud A; Agarwal SK
    Indian J Lepr; 2008; 80(2):175-8. PubMed ID: 19425513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histoid leprosy: a retrospective study of 40 cases from India.
    Kaur I; Dogra S; De D; Saikia UN
    Br J Dermatol; 2009 Feb; 160(2):305-10. PubMed ID: 19016704
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Persistent type 2 lepra reaction (erythema nodosum) and clofazimine-induced lethal enteropathy].
    Rodríguez G; Pinto R; López F; Gómez Y
    Biomedica; 2009 Mar; 29(1):18-24. PubMed ID: 19753835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relapse of lepromatous leprosy after WHO/MDT with rapid bacterial growth.
    Oliveira ML; Pierro AP; Silveira PA; Campos MM; Vilela MF
    Lepr Rev; 2002 Dec; 73(4):386-8. PubMed ID: 12549846
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Occurrence of reactions, their diagnosis and management in leprosy patients treated with multidrug therapy; experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia.
    Becx-Bleumink M; Berhe D
    Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):173-84. PubMed ID: 1522359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chromoblastomycosis in a case of borderline lepromatous leprosy with recurrent type II lepra reaction.
    Apte G; Gedam JR; Poojary S; Nagpur NG; Pai VV; Ganapathi R
    Lepr Rev; 2011 Sep; 82(3):310-5. PubMed ID: 22125940
    [No Abstract]   [Full Text] [Related]  

  • 39. Incidence of late lepra reaction among multibacillary leprosy patients after MDT.
    Vijayakumaran P; Manimozhi N; Jesudasan K
    Int J Lepr Other Mycobact Dis; 1995 Mar; 63(1):18-22. PubMed ID: 7730714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinico-pathological features of erythema nodosum leprosum: A case-control study at ALERT hospital, Ethiopia.
    Negera E; Walker SL; Girma S; Doni SN; Tsegaye D; Lambert SM; Idriss MH; Tsegay Y; Dockrell HM; Aseffa A; Lockwood DN
    PLoS Negl Trop Dis; 2017 Oct; 11(10):e0006011. PubMed ID: 29028793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.